These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 7955409
1. [14C]Methylamine accumulation in cultured human skin fibroblasts--a biochemical test for lysosomal storage and lysosomal diseases. Kopitz J, Gerhard C, Höfler P, Cantz M. Clin Chim Acta; 1994 Jun; 227(1-2):121-33. PubMed ID: 7955409 [Abstract] [Full Text] [Related]
2. Methylamine accumulation in cultured cells as a measure of the aqueous storage compartment in the laboratory diagnosis of genetic lysosomal diseases. Kopitz J, Harzer K, Kohlschütter A, Zöller B, Blenck N, Cantz M. Am J Med Genet; 1996 May 03; 63(1):198-202. PubMed ID: 8723110 [Abstract] [Full Text] [Related]
3. Accumulation of weak bases in relation to intralysosomal pH in cultured human skin fibroblasts. Hollemans M, Elferink RO, De Groot PG, Strijland A, Tager JM. Biochim Biophys Acta; 1981 Apr 22; 643(1):140-51. PubMed ID: 7236683 [Abstract] [Full Text] [Related]
4. Tilorone acts as a lysosomotropic agent in fibroblasts. Gupta DK, Gieselmann V, Hasilik A, von Figura K. Hoppe Seylers Z Physiol Chem; 1984 Aug 22; 365(8):859-66. PubMed ID: 6489934 [Abstract] [Full Text] [Related]
6. Lysosomal storage causes cellular dysfunction in mucolipidosis II skin fibroblasts. Otomo T, Higaki K, Nanba E, Ozono K, Sakai N. J Biol Chem; 2011 Oct 07; 286(40):35283-90. PubMed ID: 21846724 [Abstract] [Full Text] [Related]
7. Estimation and comparison of lysosomal and cytoplasmic pH of human fibroblasts from healthy donors and patients with lysosomal storage diseases. Ivleva TS, Ogloblina TA, Litinskaya LL, Wiederschain GYa. Biomed Sci; 1991 Oct 07; 2(4):398-402. PubMed ID: 1797144 [Abstract] [Full Text] [Related]
8. 19q13.12 microdeletion syndrome fibroblasts display abnormal storage of cholesterol and sphingolipids in the endo-lysosomal system. Zhao K, van der Spoel A, Castiglioni C, Gale S, Fujiwara H, Ory DS, Ridgway ND. Biochim Biophys Acta Mol Basis Dis; 2018 Jun 07; 1864(6 Pt A):2108-2118. PubMed ID: 29580926 [Abstract] [Full Text] [Related]
9. Drug-induced lysosomal storage of sulphated glycosaminoglycans. Fischer J, Lüllmann H, Lüllmann-Rauch R. Gen Pharmacol; 1996 Dec 07; 27(8):1317-24. PubMed ID: 9304401 [Abstract] [Full Text] [Related]
11. A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders. Rappaport J, Manthe RL, Solomon M, Garnacho C, Muro S. Mol Pharm; 2016 Feb 01; 13(2):357-368. PubMed ID: 26702793 [Abstract] [Full Text] [Related]
12. Protein catabolism in fibroblasts cultured from patients with mucolipidosis II and other lysosomal disorders. Kopitz J, Arnold A, Meissner T, Cantz M. Biochem J; 1993 Oct 15; 295 ( Pt 2)(Pt 2):577-80. PubMed ID: 8240260 [Abstract] [Full Text] [Related]
13. Drug-induced intralysosomal storage of sulfated glycosaminoglycans (GAGs): a methodical pitfall occurring with acridine derivatives. Lüllmann-Rauch R. Exp Toxicol Pathol; 1994 Oct 15; 46(4-5):315-22. PubMed ID: 7894242 [Abstract] [Full Text] [Related]
15. [Intravital determination of pH gradient between the cytoplasm and lysosomes in human fibroblasts in the normal state and in hereditary storage diseases]. Ivleva TS, Ogloblina TA, Litinskaia LL, Khrust IuR, Vidershaĭn GIa. Biull Eksp Biol Med; 1991 May 15; 111(5):495-8. PubMed ID: 1953901 [Abstract] [Full Text] [Related]